An open multicentre study of the treatment of florid schizophrenia with remoxipride
- 1 August 1985
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 72 (2) , 139-143
- https://doi.org/10.1111/j.1600-0447.1985.tb02585.x
Abstract
Remoxipride, a novel substituted benzamide, was given for 4 weeks to 18 florid schizophrenics in an open study. The mental state of the majority improved as measured by the Brief Psychiatric Rating Scale. Remoxipride itself did not appear to cause troublesome extrapyramidal effects. There were no significant adverse effects on the cardiovascular system and no significant abnormalities in laboratory tests. These results suggested that remoxipride has antipsychotic effects, and that this should be tested in controlled clinical trials.Keywords
This publication has 7 references indexed in Scilit:
- Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brainEuropean Journal of Pharmacology, 1984
- Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activitiesJournal of Medicinal Chemistry, 1982
- Multiple receptors for dopamineNature, 1979
- The nucleus accumbens–possible site of antipsychotic action of neuroleptic drugs?Psychological Medicine, 1977
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963
- The Brief Psychiatric Rating ScalePsychological Reports, 1962
- A Simple and Reliable Subclassification of Chronic SchizophreniaJournal of Mental Science, 1961